Amsterdam: CEO of the Saudi Food and Drug Authority (SFDA) Dr. Hisham Aljadhey held several meetings with international counterparts on the sidelines of his participation in the International Coalition of Medicines Regulatory Authorities (ICMRA) Summit 2025, held in Amsterdam from October 21 to 23.

According to Saudi Press Agency, the meetings included one with Director-President of the Brazilian Health Regulatory Agency (ANVISA) Dr. Leandro Safatle, as well as two meetings - one with Chairman of the Egyptian Drug Authority (EDA) Dr. Ali El-Ghamrawy, and another with Chief Executive of the British Medicines and Healthcare Products Regulatory Authority (MHRA) Lawrence Tallon.

Discussions focused on strengthening cooperation and communication between regulatory authorities to achieve common goals and enhance the safety, quality, and efficacy of medicines and vaccines.

The meetings also reviewed leading practices and policies regarding artificial intelligence to promote innovation and growth in the pharmaceutical sector, in addition to several other topics of mutual interest.

The ICMRA serves as an international platform for enhancing collaboration among regulatory bodies, addressing drug-safety challenges through innovative mechanisms, and developing related regulations and systems. This aligns with the objectives of the Health Sector Transformation Program within the Kingdom's Vision 2030.